This 1 page fact sheet from the Drug Enforcement Administration clarifies that during the Covid-19 public health emergency prescribers will be able to use telemedicine to evaluate a patient and prescribe schedule II-IV drugs. For new patients, telemedicine appointments must be conducted via audio-visual, real-time, two-way interactive communication. Prescriptions may be electronically submitted to pharmacies or prescribers may call-in prescriptions.
Funding source: U.S. Drug Enforcement Administration
DEA Information on Telemedicine (COVID-19)
The Drug Enforcement Administration's policy on prescribers' ability to prescribe schedule II-V drugs through telemedicine